Registry of Celution Device for the Processing of Adipose Derived Regenerative Cells (ADRCs) to Treat Osteoarthritis (RELIEVE)

Cytori Therapeutics

Status: Withdrawn

Conditions: Osteoarthritis

Study type: Observational

Funder types: Industry

Identifiers

NCT02736110

RELIEVE

Details and patient eligibility

About

This registry study will compile information from patients that are scheduled to receive or have received Adipose Derived Regenerative Cells (ADRCs) prepared by the Celution device to treat osteoarthritis in the knee.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Males or females > 18 years of age
• Diagnosis of osteoarthritis in one or both knees with Kellgren Lawrence grade ≥ 2 at x-ray evaluation or MRI findings of degenerative changes
• Pain with or without swelling in the affected area for >4 months

Exclusion criteria

• Know spine or disc disease or symptomatic nerve impingement contributing to pain in the affected limb
• History of documented nerve damage in the affected limb
• Pregnant or lactating status. Pregnancy as determined by a positive pregnancy test prior to procedure.